7Baggers

Acorda Therapeutics Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20190331 20190630 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 -263.54-216.51-169.48-122.45-75.42-28.418.6365.66Milllion

Acorda Therapeutics Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-11-04 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-30 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2003-09-30 
  revenue37,985,000 27,715,000 29,675,000 22,258,000 31,472,000 33,511,000 31,051,000 22,534,000 36,967,000 31,456,000 31,785,000 28,862,000 38,160,000 53,090,000 33,617,000 28,099,000 50,496,000 47,722,000 50,053,000 44,137,000 69,152,000 142,814,000 153,302,000 106,165,000 188,398,000 141,065,000 139,438,000 119,386,000 140,627,000 135,613,000 127,458,000 115,904,000 130,902,000 148,199,000 113,707,000 99,851,000 117,872,000 105,961,000 97,129,000 80,518,000 92,593,000 84,919,000 84,919,000 87,053,000 71,865,000 81,473,000 77,437,000 75,656,000 71,248,000 72,644,000 93,031,000 65,276,000 61,286,000 66,800,240 63,622,000 42,835,000 17,748,000 14,440,777 15,214,000 12,550,000 12,469,078 12,461,997 12,465,528 11,385,714 11,513,558 11,215,377 10,459,305 9,494,442 8,316,767 7,720,451 6,227,316 9,603,519 3,799,661 2,713,783 810,575 201,704 
  cost of revenue13,289,000 3,387,000 3,065,000 3,234,000 4,560,000 11,005,000 8,800,000 5,967,000 4,198,000 13,303,000 11,324,000 11,961,000 10,842,000 12,170,000 6,658,000 3,843,000 8,666,000 7,986,000 9,397,000 8,799,000 21,476,000 25,391,000 31,094,000 21,350,000 50,399,000 30,151,000 29,824,000 25,342,000 30,369,000 27,803,000 26,594,000 23,345,000 26,560,000 24,900,000 22,867,000 18,605,000 25,135,000 20,734,000 19,058,000 15,688,000 18,535,000 17,372,000 17,372,000 17,094,000 13,643,000 16,364,000 14,920,000 13,734,000 12,623,000 13,593,000 28,559,000 12,048,000 12,050,000 12,944,278 11,666,000 7,832,000 3,076,000 3,111,431 2,767,000 2,952,000 2,558,937 2,838,169 2,700,772 2,829,579 2,986,392 2,609,373 2,181,565 2,010,621 1,554,299 3,085,428 1,652,281 1,343,906 1,041,218 2,858,160 757,990 
  gross profit24,696,000 24,328,000 26,610,000 19,024,000 26,912,000 22,506,000 22,251,000 16,567,000 32,769,000 18,153,000 20,461,000 16,901,000 27,318,000 40,920,000 26,959,000 24,256,000 41,830,000 39,736,000 40,656,000 35,338,000 47,676,000 117,423,000 122,208,000 84,815,000 137,999,000 110,914,000 109,614,000 94,044,000 110,258,000 107,810,000 100,864,000 92,559,000 104,342,000 123,299,000 90,840,000 81,246,000 92,737,000 85,227,000 78,071,000 64,830,000 74,058,000 67,547,000 67,547,000 69,959,000 58,222,000 65,109,000 62,517,000 61,922,000 58,625,000 59,051,000 64,472,000 53,228,000 49,236,000 53,855,962 51,956,000 35,003,000 14,672,000 11,329,346 12,447,000 9,598,000 9,910,141 9,623,828 9,764,756 8,556,135 8,527,166 8,606,004 8,277,740 7,483,821 6,762,468 4,635,023 4,575,035 8,259,613 2,758,443 -144,377 52,585 201,704 
  operating expenses                                                                            
  research and development1,008,999 1,207,000 1,550,000 1,386,000 1,203,000 1,383,000 1,525,000 1,694,000 1,366,000 1,931,000 2,374,000 4,749,000 4,323,000 5,729,000 5,255,000 7,705,000 9,023,000 16,073,000 18,959,000 16,028,000 27,058,000 22,855,000 25,910,000 30,560,000 35,142,000 33,286,000 51,184,000 46,493,000 53,797,000 54,777,000 50,293,000 44,570,000 43,988,000 43,356,000 31,229,000 30,636,000 25,921,000 16,578,000 16,448,000 14,522,000 14,302,000 13,839,000 13,839,000 13,216,000 12,520,000 18,191,000 12,031,000 12,634,000 11,025,000 10,304,000 9,088,000 12,008,000 10,708,000 7,972,431 7,970,000 6,596,000 8,062,000 10,629,155 8,198,000 7,867,000 7,916,936 10,846,328 8,650,305 8,058,113 9,592,322 9,556,019 5,602,828 4,007,479 3,243,953 3,162,428 2,594,466 3,021,016 3,276,869 3,237,051 3,217,514 12,672,955 
  sales, general and administrative                                                                            
  total operating expenses23,215,000 32,050,000 31,066,000 31,591,000 22,594,000 32,071,000 39,283,000 36,323,000 37,497,000 39,245,000 42,433,000 46,408,000 44,890,000 53,355,000 51,602,000 56,504,000 57,937,000 72,467,000 76,845,000 71,317,000 63,877,000 66,426,000 70,173,000 78,161,000 74,660,000 74,027,000 100,518,000 98,197,000 112,478,000 109,143,000 103,349,000 96,352,000 96,972,000 94,412,000 84,048,000 79,405,000 82,377,000 64,398,000 67,092,000 61,414,000 61,309,000 56,175,000 56,175,000 61,219,000 60,718,000 63,785,000 52,152,000 56,864,000 49,770,000 46,024,000 43,806,000 52,308,000 48,795,000 49,739,998 38,693,000 40,708,000 34,776,000 33,362,412 31,448,000 31,793,000 27,938,640 30,412,173 29,018,436 25,628,471 24,852,159 23,167,377 17,240,911 15,601,589 14,567,507 11,387,446 11,326,979 10,863,618 10,116,993 8,774,402 8,549,497 23,714,663 
  operating income1,481,000 -2,519,000 -3,632,000 -12,567,000 4,312,000 -9,565,000 -17,032,000 -16,703,000 -11,559,000 -23,009,000 -15,689,000 -28,781,000 -78,395,000 16,037,000 -9,551,000 -6,169,000 14,486,000 -259,350,000 -23,389,000 -43,379,000 -49,301,000 28,297,000 59,035,000 454,000 -218,079,000 -2,159,000 2,696,000 -15,273,000 714,000 -5,472,000 -14,033,000 -17,191,000 3,871,000 25,687,000 5,692,000 -1,259,000 1,169,000 20,829,000 10,979,000 3,416,000 12,749,000 11,372,000 11,372,000 8,740,000 -2,496,000 1,324,000 10,365,000 5,058,000 8,855,000 13,027,000 20,666,000 920,000 441,000 4,115,964 13,263,000 -5,705,000 -20,104,000 -22,033,066 -19,001,000 -22,195,000 -18,028,499 -20,788,345 -19,253,680 -17,072,336 -16,324,993 -14,561,373 -8,963,171 -8,117,768 -7,805,039 -6,752,423 -6,751,944 -2,604,005 -7,358,550 -8,918,779 -8,496,912 -23,273,122 
  net income-217,761,000 -8,888,000 -9,381,000 -16,824,000 19,142,000 -13,854,000 -46,682,000 -24,522,000 -20,567,000 -27,071,000 -22,864,000 -33,451,000 -83,048,000 7,347,000 -17,421,000 -6,472,000 65,660,000 -263,535,000 -27,486,000 -47,605,000 9,595,000 -13,911,000 46,197,000 -8,199,000 -171,064,000 -25,195,000 -8,196,000 -18,904,000 -3,094,000 -12,725,000 -18,279,000 -520,000 9,205,000 3,941,000 997,000 -3,085,000 331,000 11,953,000 4,685,000 703,000 6,193,000 7,477,000 7,477,000 3,910,000 -1,139,000 132,973,000 9,594,000 4,545,000 7,846,000 12,694,000 18,867,000 -285,000 -672,000 3,670,819 12,438,000 -6,764,000 -21,114,000 -22,473,590 -19,430,000 -23,329,000 -18,708,144 -20,231,543 -18,855,762 -18,822,458 -16,430,875 -13,729,575 -8,532,440 -8,163,712 -7,548,740 -7,009,569 -7,169,666 -2,896,353 -6,943,782 -9,566,461 -8,654,595 -23,223,592 

We provide you with 20 years income statements for Acorda Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Acorda Therapeutics stock. Explore the full financial landscape of Acorda Therapeutics stock with our expertly curated income statements.

The information provided in this report about Acorda Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.